When vaccine production facilities in South Africa lost power for 72 consecutive hours last March, 3.8 million COVID-19 doses went to waste. This incident exposes a critical question: How can we ensure energy security becomes an integral part of pharmaceutical infrastructure planning? The World Health Organization estimates 35% of vaccine manufacturing interruptions stem from energy supply issues – a vulnerability magnified by climate change and geopolitical tensions.
Enter your inquiry details, We will reply you in 24 hours.
Brand promise worry-free after-sales service